KVP Capital Advisors »

Vyne Therapeutics shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $290k 501k 0.58

More positions owned by KVP Capital Advisors

Terns Pharmaceuticals (TERN)
Praxis Precision Medicines I Com New (PRAX)
Axsome Therapeutics (AXSM)
Jazz Pharmaceuticals Call Call Option
Aadi Bioscience (WHWK)
Trevi Therapeutics (TRVI)
Insmed Com Par $.01 (INSM)
Protagonist Therapeutics (PTGX)
Disc Medicine (IRON)
Mbx Biosciences (MBX)
Savara (SVRA)
Travere Therapeutics (TVTX)
Edgewise Therapeutics (EWTX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Soleno Therapeutics (SLNO)

View all positions for KVP Capital Advisors

Top funds holding Vyne Therapeutics

Baker Bros. Advisors
Acadian Asset Management
Acorn Capital Advisors
KVP Capital Advisors
Shay Capital
Vanguard Group
Ikarian Capital
ADAR1 Capital Management
Geode Capital Management
Two Sigma Investments
Jane Street
Boothbay Fund Management
Bridgeway Capital Management
UBS Group
Susquehanna International

View all funds holding Vyne Therapeutics